BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36443148)

  • 1. Anemia in inflammatory bowel disease course is associated with patients' worse outcome.
    Hsiao PY; Weng MT; Chang CH; Huang LY; Tung CC; Leong YL; Shieh MJ; Wong JM; Wei SC
    J Formos Med Assoc; 2023 Jul; 122(7):549-556. PubMed ID: 36443148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and quality of life in patients with inflammatory bowel disease-associated anemia in Southeast China.
    Xue M; Chen J; Zheng W; Liu Y; Lin Y; Wang C
    Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):275-284. PubMed ID: 36708298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort.
    Koutroubakis IE; Ramos-Rivers C; Regueiro M; Koutroumpakis E; Click B; Schwartz M; Swoger J; Baidoo L; Hashash JG; Barrie A; Dunn MA; Binion DG
    J Clin Gastroenterol; 2016 Sep; 50(8):638-43. PubMed ID: 26485103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANEMIA AND IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE PATIENTS IN A REFERRAL CENTER IN BRAZIL: PREVALENCE AND RISK FACTORS.
    Parra RS; Feitosa MR; Ferreira SDC; Rocha JJRD; Troncon LEA; FÉres O
    Arq Gastroenterol; 2020; 57(3):272-277. PubMed ID: 33027478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study.
    Foteinogiannopoulou K; Karmiris K; Axiaris G; Velegraki M; Gklavas A; Kapizioni C; Karageorgos C; Kateri C; Katsoula A; Kokkotis G; Koureta E; Lamouri C; Markopoulos P; Palatianou M; Pastras P; Fasoulas K; Giouleme O; Zampeli E; Theodoropoulou A; Theocharis G; Thomopoulos K; Karatzas P; Katsanos KH; Kapsoritakis A; Kourikou A; Mathou N; Manolakopoulos S; Michalopoulos G; Michopoulos S; Boubonaris A; Bamias G; Papadopoulos V; Papatheodoridis G; Papaconstantinou I; Pachiadakis I; Soufleris K; Tzouvala M; Triantos C; Tsironi E; Christodoulou DK; Koutroubakis IE;
    BMC Gastroenterol; 2021 Jun; 21(1):269. PubMed ID: 34187376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study.
    Eriksson C; Henriksson I; Brus O; Zhulina Y; Nyhlin N; Tysk C; Montgomery S; Halfvarson J
    Aliment Pharmacol Ther; 2018 Sep; 48(6):638-645. PubMed ID: 30069892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
    Vegh Z; Kurti Z; Gonczi L; Golovics PA; Lovasz BD; Szita I; Balogh M; Pandur T; Vavricka SR; Rogler G; Lakatos L; Lakatos PL
    Scand J Gastroenterol; 2016 Jul; 51(7):848-54. PubMed ID: 26880133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort.
    Lee WS; Ng RT; Chan KW; Lau YL
    World J Gastroenterol; 2016 Dec; 22(48):10653-10662. PubMed ID: 28082818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence rate of anemia in inflammatory bowel diseases.
    Atuğ Ö; Kani HT; Banzragch M; İmeryüz N; Akın H
    Turk J Gastroenterol; 2016 Mar; 27(2):143-8. PubMed ID: 27015619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease.
    Nelson AD; Fluxá D; Caldera F; Farraye FA; Hashash JG; Kröner PT
    Dig Dis Sci; 2023 Jun; 68(6):2597-2603. PubMed ID: 37027107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Grade Dysplasia in Inflammatory Bowel Disease: Indication for Colectomy.
    Olecki EJ; Perez Hoguin RA; King S; Razavi NC; Scow JS
    Dis Colon Rectum; 2023 Feb; 66(2):262-268. PubMed ID: 35714339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Sarcopenia on Clinical Course of Inflammatory Bowel Disease in Korea.
    Nam K; Lee JY; Ko Y; Kim KW; Lee HS; Hong SW; Park JH; Hwang SW; Yang DH; Ye BD; Byoun JS; Myung SJ; Yang SK; Park SH
    Dig Dis Sci; 2023 Jun; 68(6):2165-2179. PubMed ID: 36693962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life aspects of the 'Periodontitis prevalence in ulcerative colitis and Crohn's disease' (PPCC) cohort.
    Bertl K; Tsakos G; Pandis N; Bogren A; Burisch J; Stavropoulos A
    J Clin Periodontol; 2023 Dec; 50(12):1601-1620. PubMed ID: 37670508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.
    Voegtlin M; Vavricka SR; Schoepfer AM; Straumann A; Voegtlin J; Rogler G; Ballabeni P; Pittet V; Buser A; Fried M; Beglinger C;
    J Crohns Colitis; 2010 Dec; 4(6):642-8. PubMed ID: 21122574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.
    Abenavoli L; Spagnuolo R; Scarlata GGM; Scarpellini E; Boccuto L; Luzza F
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38003983
    [No Abstract]   [Full Text] [Related]  

  • 20. Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients.
    Lucendo AJ; Arias Á; Roncero Ó; Hervías D; Verdejo C; Naveas-Polo C; Bouhmidi A; Lorente R; Alcázar LM; Salueña I; García-Quiñones JA; Carrillo-Ramos MJ
    Dig Liver Dis; 2017 Apr; 49(4):405-411. PubMed ID: 28096058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.